quinoxalines has been researched along with Hyperplasia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arner, A; de Sá, VP; Ekblad, E; Harnek, J; Stenram, U; Zoucas, E | 1 |
| Denda, M; Fuziwara, S; Ikeyama, K | 1 |
| Cambria, RA; Gloviczki, P; Lowell, RC; Miller, VM | 1 |
| Bergman, J; Möller, L; Rozell, BL; Skarin, T; Toftgård, R | 1 |
| Bidouard, JP; Breugnot, C; Mahlberg, F; Perrault, LP; Vanhoutte, PM; Vilaine, JP; Villeneuve, N | 1 |
| Archer, CL; Haas, GP; Jones, RF; Morse, P; Shirai, T; Wang, CY | 1 |
| Korviakov, VS; Sidorina, NG | 1 |
| Tucker, MJ | 1 |
| Haddow, A; Ross, WC; Timmis, GM | 1 |
9 other study(ies) available for quinoxalines and Hyperplasia
| Article | Year |
|---|---|
Intimal hyperplasia in balloon dilated coronary arteries is reduced by local delivery of the NO donor, SIN-1 via a cGMP-dependent pathway.
Topics: Actins; Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclic GMP; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Guanylate Cyclase; Hyperplasia; Intermediate Filaments; Molsidomine; Myosins; NAD(P)H Dehydrogenase (Quinone); NADP; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Signal Transduction; Sus scrofa; Time Factors; Tunica Intima | 2011 |
Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption.
Topics: Administration, Topical; Animals; Calcium; Cell Membrane Permeability; Cells, Cultured; Enzyme Inhibitors; Homeostasis; Humans; Hyperplasia; Keratinocytes; Male; Mice; Mice, Hairless; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxadiazoles; Penicillamine; Quinoxalines; Skin | 2007 |
Chronic changes in blood flow alter endothelium-dependent responses in autogenous vein grafts in dogs.
Topics: Acetylcholine; Adenosine Diphosphate; Adrenergic alpha-Agonists; Animals; Arginine; Arteriovenous Shunt, Surgical; Blood Flow Velocity; Brimonidine Tartrate; Calcimycin; Constriction; Dinoprost; Dogs; Endothelins; Endothelium, Vascular; Femoral Artery; Femoral Vein; Hyperplasia; Male; Models, Biological; Neovascularization, Pathologic; Nitric Oxide; omega-N-Methylarginine; Quinoxalines; Thrombin; Tunica Intima; Vascular Patency | 1994 |
Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Benzoyl Peroxide; Carcinogens; Dermatitis, Contact; Female; Hyperplasia; Indoles; Mice; Mice, Inbred SENCAR; Precancerous Conditions; Quinoxalines; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1999 |
Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation.
Topics: Adrenergic alpha-Agonists; Animals; Arteriosclerosis; Biological Transport; Brimonidine Tartrate; Calcimycin; Calcium; Cholesterol, HDL; Cholesterol, LDL; Coronary Vessels; Diet, Atherogenic; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Erythrocyte Count; Female; Free Radical Scavengers; Heart Transplantation; Hematocrit; Hemoglobins; Hypercholesterolemia; Hyperplasia; Ionophores; Male; Myocardium; Postoperative Period; Potassium Chloride; Quinoxalines; Serotonin; Swine; Transplantation, Homologous; Tunica Intima; Vasodilation | 2000 |
Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4,5-f]quinoxaline and 3, 2'-dimethyl-4-aminobiphenyl in the rat.
Topics: Aminobiphenyl Compounds; Animals; Animals, Newborn; Body Weight; Carcinogens; Carcinoma, Transitional Cell; Colonic Neoplasms; Hyperplasia; Imidazoles; Male; Mutagens; Prostatic Neoplasms; Pyridines; Quinoxalines; Rats; Rats, Inbred ACI; Urinary Bladder Neoplasms | 2000 |
[Combined drug therapy in patients with chronic otitis media and mucositis].
Topics: Adolescent; Adult; Anti-Infective Agents; Chronic Disease; Combined Modality Therapy; Ear Diseases; Ear, Middle; Female; Humans; Hyperplasia; Laser Therapy; Magnetics; Male; Middle Aged; Mucous Membrane; Otitis Media; Quinoxalines | 2000 |
Carcinogenic action of quinoxaline 1,4-dioxide in rats.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Hyperplasia; Kidney Neoplasms; Liver Neoplasms; Male; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive, Peripheral; Nose Neoplasms; Precancerous Conditions; Quinoxalines; Rats; Sex Factors | 1975 |
The chain of unexpected discovery: xanthopterin-stimulated renal mitosis.
Topics: Animals; Biochemistry; Creativity; History, 20th Century; Hyperplasia; Hypertrophy; Hypoxanthines; Kidney; Kidney Diseases; Mitosis; Pteridines; Purines; Pyrazines; Pyrimidines; Quinoxalines; Rats; Stimulation, Chemical; Structure-Activity Relationship; United Kingdom; Xanthine Oxidase; Xanthopterin | 1972 |